Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Amasyn
AddedFeb 18, 2024
UpdatedJun 18, 2026
Amasyn

Amasyn

AmaSyn Inc.: A US-based biotech firm specializing in product sourcing and distribution.

HQ
Logan, UT, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

AmaSyn Inc., founded in Logan, Utah, is a biotechnology company focused on product sourcing and distribution. The company's core mission is to streamline the supply chain for biotech products, ensuring high-quality and reliable delivery to its clients. AmaSyn aims to be a leader in the biotech distribution market by leveraging advanced logistics and a deep understanding of the industry.

Notable affiliated individuals and investors have not been publicly disclosed. However, AmaSyn has made significant strides in optimizing the biotech supply chain, contributing to more efficient and effective distribution networks. The company's impact is evident in its ability to meet the growing demands of the biotech sector, ensuring that critical products reach their destinations promptly and securely.

Amasyn - Similar Companies

Synonym logo

Synonym

synonym.bio

Sasya logo

Sasya

sasyabio.com

TD SYNNEX logo

TD SYNNEX

tdsynnex.com

AmnioLife logo

AmnioLife

Synergenics logo

Synergenics

synergenics.net

Amnio Technology logo

Amnio Technology

AmideBio logo

AmideBio

amidebio.com

Adipogenix logo

Adipogenix

Asimov logo

Asimov

asimov.com

Amyris logo

Amyris

amyris.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Artizan Biosciences logo

Artizan Biosciences

Ammonett Pharma logo

Ammonett Pharma

AMCON Distributing Company logo

AMCON Distributing Company

amcon.com

Armetheon logo

Armetheon

Amasyn - Quick Facts

Who are Amasyn's competitors?

Companies similar to Amasyn include Synonym, Sasya, TD SYNNEX and AmnioLife.

When was Amasyn founded?

Amasyn was founded in 2012.

Where is Amasyn's headquarters located?

Amasyn's headquarters is located in Logan, UT, US.

When was Amasyn's last funding round?

Amasyn's most recent funding round was for $340k (USD) in August 2013.

How much has Amasyn raised to-date?

As of Aug 8, 2013, Amasyn has raised a total of $340k (USD).

How many employees does Amasyn have?

Amasyn has 30 employees as of Feb 5, 2024.

Amasyn - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biotech Products
Tags
  • Distribution
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified